If you are going to trade biotechs, you need to subscribe to a good quality newsletter devoted to biotechs, otherwise you are going to be very frustrated. I subscribe to BioRunUp and the annual subscription is usually made up in a trade or two.
BioRunUp laid out their trades for BPAX well in advance, and they were not long the stock, but shorted the FDA approval.
Market Data 
Markets 
AI
